Search Results 661-670 of 1738 for 批改网ai写作,ai写作的网文,ai画图的网址,下载ai 的网站,ai音乐生成网址,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

  1. Zenith® p-Branch® OTS Multicenter Study - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  3. A First-in-Human, Phase 1 Dose-Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BJ-005 in Patients With Advanced Solid Tumor or Lymphoma - Mayo Clinic

    About this study. The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of BJ-005 in patients with advanced solid tumor or ...

  4. Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. News - Translational Cell Biology of Parkinson's Disease Laboratory - Mayo Clinic Research

    Read news highlighting gene studies in Parkinson's disease from Mayo Clinic's Translational Cell Biology of Parkinson's Disease Lab led by Wolfdieter ...

  6. An Open Label Clinical Study To Evaluate Tanruprubart (Also Commonly Known As ANX005) In Participants With Guillain-Barré Syndrome (FORWARD Study) - Mayo Clinic

    The goal of this open label study is to measure pharmacokinetics, pharmacodynamics, early efficacy, and safety of tanruprubart in adult and pediatric ...

  7. Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy

    This is a multicenter, international, double-blind study of the administration of mavacamten in participants with symptomatic obstructive HCM (oHCM).

  8. A Study to Compare Tisagenlecleucel vs. Standard of Care in Adult Patients with Aggressive B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    This is a randomized, open label, multicenter phase III trial to determine the efficacy and safety of tisagenlecleucel treatment strategy in adult patients with ...

  9. Patient Reported Outcomes of Nontuberculous Mycobacterial Pulmonary Disease - Mayo Clinic

    About this study. The purpose of this study is e to better understand the trajectory of patient-reported outcomes (PROs), e.g. respiratory symptoms and ...

  10. Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma - Mayo Clinic

    About this study. Phase 1b of the study will evaluate the safety of talimogene laherparepvec in combination with ipilimumab. Phase 2 is a randomized study ...